Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: 1&1 AG:  Deutsche Telekom loses in Court: 1&1 builds Europe's most advanced 5G network: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png
EQS-News: 1&1 AG: Deutsche Telekom loses in Court: 1&1 builds Europe's most advanced 5G network
EQS-News: 1&1 AG: Deutsche Telekom loses in Court: 1&1 builds Europe's most advanced 5G network
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: United Internet AG: Change in Management Board of United Internet AG: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24075/330px-UnitedInternet_logo.svg.png
EQS-News: United Internet AG: Change in Management Board of United Internet AG
EQS-News: United Internet AG: Change in Management Board of United Internet AG
EQS-News: United Internet AG: Change in Management Board of United Internet AG: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24075/330px-UnitedInternet_logo.svg.png
EQS-News: United Internet AG: Change in Management Board of United Internet AG
EQS-News: United Internet AG: Change in Management Board of United Internet AG
LivaNova erhält 510(k)-Freigabe der US-amerikanischen FDA für Essenz-Herz-Lungen-Maschine für kardiopulmonale Bypassverfahren: https://mms.businesswire.com/media/20230309005788/de/1735168/5/Essenz_DMcDonald_Milano_2023_03_02-12.jpg
LivaNova erhält 510(k)-Freigabe der US-amerikanischen FDA für Essenz-Herz-Lungen-Maschine für kardiopulmonale Bypassverfahren


LivaNova PLC (Nasdaq: LIVN), ein marktführendes Unternehmen im Bereich medizintechnische Innovationen, gab heute bekannt, dass es die 510(k)-Freigabe von der US-amerikanischen Food and Drug

LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures: https://mms.businesswire.com/media/20230309005787/en/1735168/5/Essenz_DMcDonald_Milano_2023_03_02-12.jpg
LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Essenz™

EQS-News: Invitation to MorphoSys’ Full Year Results 2022 Conference Call on  March 16, 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: Invitation to MorphoSys’ Full Year Results 2022 Conference Call on March 16, 2023
EQS-News: Invitation to MorphoSys’ Full Year Results 2022 Conference Call on March 16, 2023
EQS-News: Invitation to MorphoSys’ Full Year Results 2022 Conference Call on  March 16, 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: Invitation to MorphoSys’ Full Year Results 2022 Conference Call on March 16, 2023
EQS-News: Invitation to MorphoSys’ Full Year Results 2022 Conference Call on March 16, 2023
Semtech Unveils New Brand Reflecting Company’s Vision to Enable a Smarter, More Connected and Sustainable Planet: https://mms.businesswire.com/media/20230309005315/en/1734402/5/semtech_graphic.jpg
Semtech Unveils New Brand Reflecting Company’s Vision to Enable a Smarter, More Connected and Sustainable Planet


Semtech Corporation (Nasdaq: SMTC), a high-performance semiconductor, IoT systems and Cloud connectivity service provider, today unveiled a refreshed brand reflecting the company’s redefined

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: Siltronic closes 2022 with a record in sales and EBITDA: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png
EQS-News: Siltronic closes 2022 with a record in sales and EBITDA
EQS-News: Siltronic closes 2022 with a record in sales and EBITDA
EQS-News: Siltronic closes 2022 with a record in sales and EBITDA: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png
EQS-News: Siltronic closes 2022 with a record in sales and EBITDA
EQS-News: Siltronic closes 2022 with a record in sales and EBITDA
EQS-Adhoc: LEG Immobilien SE: Suspension of the dividend for business year 2022 in order to strengthen the balance sheet – Increase in AFFO guidance: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23728/375px-LEG_NRW_logo.svg.png
EQS-Adhoc: LEG Immobilien SE: Suspension of the dividend for business year 2022 in order to strengthen the balance sheet – Increase in AFFO guidance
EQS-Adhoc: LEG Immobilien SE: Suspension of the dividend for business year 2022 in order to strengthen the balance sheet – Increase in AFFO guidance
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: FUCHS successfully completes challenging year 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23712/240px-Fuchs-Petrolub-AG-Logo.svg.png
EQS-News: FUCHS successfully completes challenging year 2022
EQS-News: FUCHS successfully completes challenging year 2022
EQS-Adhoc: Brenntag SE resolves on share buyback program with a total volume of up to EUR 750 million: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23703/Brenntag.svg.png
EQS-Adhoc: Brenntag SE resolves on share buyback program with a total volume of up to EUR 750 million
EQS-Adhoc: Brenntag SE resolves on share buyback program with a total volume of up to EUR 750 million
EQS-News: Siltronic AG will complete planned management change after the Annual General Meeting: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png
EQS-News: Siltronic AG will complete planned management change after the Annual General Meeting
EQS-News: Siltronic AG will complete planned management change after the Annual General Meeting
EQS-News: Siltronic AG will complete planned management change after the Annual General Meeting: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png
EQS-News: Siltronic AG will complete planned management change after the Annual General Meeting
EQS-News: Siltronic AG will complete planned management change after the Annual General Meeting
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: FUCHS extends Executive Board contracts of Dr. Timo Reister and Dr. Ralph Rheinboldt: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23712/240px-Fuchs-Petrolub-AG-Logo.svg.png
EQS-News: FUCHS extends Executive Board contracts of Dr. Timo Reister and Dr. Ralph Rheinboldt
EQS-News: FUCHS extends Executive Board contracts of Dr. Timo Reister and Dr. Ralph Rheinboldt
EQS-News: Nagarro targets change in auditors and announces Capital Markets Day: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-News: Nagarro targets change in auditors and announces Capital Markets Day
EQS-News: Nagarro targets change in auditors and announces Capital Markets Day
EQS-News: Nagarro targets change in auditors and announces Capital Markets Day: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-News: Nagarro targets change in auditors and announces Capital Markets Day
EQS-News: Nagarro targets change in auditors and announces Capital Markets Day
EQS-News: Schaeffler AG: Schaeffler publishes 2022 Sustainability Report: https://upload.wikimedia.org/wikipedia/commons/thumb/7/72/Schaeffler_logo.svg/640px-Schaeffler_logo.svg.png
EQS-News: Schaeffler AG: Schaeffler publishes 2022 Sustainability Report
EQS-News: Schaeffler AG: Schaeffler publishes 2022 Sustainability Report
EQS-News: Schaeffler AG: Schaeffler Group closes 2022 with solid earnings: https://upload.wikimedia.org/wikipedia/commons/thumb/7/72/Schaeffler_logo.svg/640px-Schaeffler_logo.svg.png
EQS-News: Schaeffler AG: Schaeffler Group closes 2022 with solid earnings
EQS-News: Schaeffler AG: Schaeffler Group closes 2022 with solid earnings
EQS-News: GEA exceeds upgraded targets for 2022 and proposes higher dividend: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23714/375px-GEA_Group_2010_logo.svg.png
EQS-News: GEA exceeds upgraded targets for 2022 and proposes higher dividend
EQS-News: GEA exceeds upgraded targets for 2022 and proposes higher dividend